Sign in to view content

Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss

Scott W. Cousins, MD

Video
Published 2019

Related

Mitochondria-Targeted Drug Elamipretide for Treatment of Vision Loss in Dry AMD With Noncentral Geographic Atrophy
Scott W. Cousins, MD
Annual Meeting Talks
2019
Suprachoroidally delivered gene therapy via non-viral DNA nanoparticles
Christine Kay, MD
On Demand Cases, Courses, and Papers
2019
Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy: Pooled Analysis of 5 DRCR.net Trials
Hani Salehi-Had, MD
Updates from the Field

Category: AMD-Non-Neovascular

See more